Skip to main content
. 2017 May 16;29(5):896–901. doi: 10.1589/jpts.29.896

Table 3. Visual Analogue Scale (VAS) evaluations of Group I and Group II.

Group I Group II


Mean ± SD Med (Min–Max) Mean ± SD Med (Min–Max)
VAS
Pre-injection 7.2 ± 1.2 7 5–9 7.4 ± 1.1 7 4–9
1 month 3.6 ± 0.5 4* 3–4 3.7 ± 0.8 4* 1–5
3 months 3.5 ± 0.5 3* 3–4 3.0 ± 0.7 3* 1–4
6 months 2.7 ± 0.5 3* 2–3 2.6 ± 0.5 3* 2–3

Mann-Whitney U test/Wilcoxon test. *Significant difference (p˂0.05) when compared to the pre-injection evaluation of the same group